HomeClinical TopicsFDA approves treatment for opioid-induced constipation

FDA approves treatment for opioid-induced constipation

On September 16, the U.S. Food and Drug Administration (FDA) approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content